Covered recipient · General Payments record
IAN PATRICK COE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2023–2024
$255.74
- Reported across 13 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $198.89 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $41.55 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $40.65 | 2 |
| Amgen Inc. | $34.99 | 2 |
| Edwards Lifesciences Corporation | $23.98 | 1 |
| Exact Sciences Corporation | $19.81 | 1 |
| Novo Nordisk AS | $18.96 | 1 |
| PFIZER INC. | $18.95 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $16.56 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117226420 | CMS |
| Amgen Inc. | $18.43 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111551738 | CMS |
| Edwards Lifesciences Corporation | $23.98 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138863243 | CMS |
| Exact Sciences Corporation | $19.81 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114542761 | CMS |
| Lilly USA, LLC | $17.67 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135030756 | CMS |
| Lilly USA, LLC | $23.88 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135030754 | CMS |
| Novartis Pharmaceuticals Corporation | $24.87 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086763933 | CMS |
| Novartis Pharmaceuticals Corporation | $15.78 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086763939 | CMS |
| Novo Nordisk Inc | $18.96 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096797222 | CMS |
| PFIZER INC. | $18.95 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132029757 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.